M Hidalgo Selected Research

M Hidalgo Research Topics

Disease

23	Neoplasms (Cancer) 10/2017 - 01/2000
11	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 12/2000
5	Breast Neoplasms (Breast Cancer) 06/2016 - 07/2003
4	Adenocarcinoma 10/2017 - 07/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2014 - 12/2000
4	Diarrhea 03/2008 - 01/2000
3	Infections 07/2017 - 05/2000
3	Neutropenia 05/2001 - 01/2000
3	Fever (Fevers) 05/2001 - 01/2000
2	Disease Progression 02/2018 - 01/2011
2	Hypertension (High Blood Pressure) 07/2017 - 08/2014
2	Hypersensitivity (Allergy) 07/2017 - 05/2001
2	Hernia (Hernias) 10/2005 - 12/2001
1	Gallstones (Gallstone) 11/2021
1	Rupture 08/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2017
1	Asthma (Bronchial Asthma) 07/2017
1	Hypercholesterolemia 07/2017
1	Ulcer 07/2017
1	Obesity 07/2017
1	Type 2 Diabetes Mellitus (MODY) 07/2017
1	Heartburn (Pyrosis) 07/2017
1	Melanoma (Melanoma, Malignant) 12/2014
1	Fatigue 08/2014
1	Abdominal Pain (Pain, Abdominal) 08/2014
1	Residual Neoplasm 08/2013
1	Adenocarcinoma of Lung 07/2013
1	Carcinoma (Carcinomatosis) 03/2013
1	Primary Hyperparathyroidism 07/2012
1	Colorectal Neoplasms (Colorectal Cancer) 01/2011
1	Frailty 01/2011
1	Microsatellite Instability 08/2009
1	Lung Neoplasms (Lung Cancer) 03/2008
1	Exanthema (Rash) 03/2008
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2007
1	Squamous Cell Carcinoma of Head and Neck 04/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2007
1	Postoperative Pain 10/2005
1	Inguinal Hernia (Direct Inguinal Hernia) 02/2004
1	Shock 06/2003
1	Incisional Hernia 12/2001

Drug/Important Bio-Agent (IBA)

7	Gemcitabine FDA Link 09/2016 - 12/2000
4	ErbB Receptors (EGF Receptor)IBA 03/2008 - 07/2001
3	130-nm albumin-bound paclitaxelIBA 09/2016 - 08/2013
3	Biomarkers (Surrogate Marker)IBA 07/2013 - 01/2009
3	Sirolimus (Rapamycin)FDA Link 08/2010 - 12/2000
3	temsirolimus FDA Link 08/2010 - 12/2000
2	Monoclonal AntibodiesIBA 07/2013 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 08/2009 - 12/2000
2	Tyrosine Kinase InhibitorsIBA 03/2008 - 07/2001
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2007 - 07/2001
2	Hormones (Hormone)IBA 10/2004 - 07/2003
2	EstersIBA 10/2004 - 12/2000
2	Tamoxifen FDA LinkGeneric 06/2004 - 07/2003
2	Matrix Metalloproteinases (MMPs)IBA 02/2001 - 01/2000
2	Matrix Metalloproteinase InhibitorsIBA 02/2001 - 01/2000
1	Sucrose (Saccharose)IBA 08/2020
1	AcidsIBA 07/2017
1	NVP-BKM120IBA 06/2016
1	Phosphotransferases (Kinase)IBA 06/2016
1	tyrosine receptor (receptor, tyrosine)IBA 06/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2014
1	Alkaline PhosphataseIBA 08/2014
1	vatalanib (PTK787)IBA 08/2014
1	Ertapenem (Invanz)FDA Link 03/2014
1	CollagenIBA 08/2013
1	MK-4721IBA 07/2013
1	AntigensIBA 07/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2013
1	Estrogen ReceptorsIBA 03/2013
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013
1	GuanosineIBA 02/2013
1	Collagen Type I (Type I Collagen)IBA 07/2012
1	collagen type I trimeric cross-linked peptideIBA 07/2012
1	ProcollagenIBA 07/2012
1	Cetuximab (Erbitux)FDA Link 01/2011
1	TOR Serine-Threonine KinasesIBA 08/2010
1	MTOR InhibitorsIBA 08/2010
1	ON 01910IBA 01/2009
1	Gefitinib (Iressa)FDA Link 03/2008
1	PlatinumIBA 03/2008
1	troxacitabineIBA 02/2008
1	thiamine triphosphorate (TTP)IBA 04/2007
1	Adhesives (Glues)IBA 10/2005
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 10/2004
1	LipidsIBA 10/2004
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2004
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 10/2004
1	NF-kappa B (NF-kB)IBA 06/2004
1	Estrogens (Estrogen)FDA Link 06/2004
1	Eicosapentaenoic AcidIBA 07/2003
1	Polypropylenes (Polypropylene)IBA 12/2001

Therapy/Procedure

12	Therapeutics 10/2017 - 12/2000
6	Drug Therapy (Chemotherapy) 02/2018 - 05/2000
2	Neoadjuvant Therapy 10/2017 - 09/2016
1	Cholecystectomy 11/2021
1	Herniorrhaphy 02/2004
1	Lasers (Laser) 06/2003
1	Liver Transplantation 12/2001